
Rhythm
RHY.AXRhythm Biosciences Limited Price (RHY.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
228,296,917
(3.0492)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.042-0.14
- Market Cap 24.37M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Diagnostics & Research
- ceo: Dr. David Atkins M.B.A., Ph.D.
- IPO Date: December, 06, 2017
- Country: AU
- Currency: AUD
- Headquaters: Parkville, VIC
- Employees: No Data
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
